Diagnostic Accuracy of the Interferon-gamma Release Assay in Acquired Immunodeficiency Syndrome Patients with Suspected Tuberculosis Infection: a Meta-analysis

Overview

Journal Infection

Date 2022 Mar 6

PMID 35249210

Authors

Hao Chen

Atsushi Nakagawa

Mikio Takamori

Seitarou Abe

Daisuke Ueno

Nobuyuki Horita

Seiya Kato

Nobuhiko Seki

Affiliations

Soon will be listed here.

Abstract

Purpose: The diagnostic accuracy of the interferon-gamma release assay (IGRA) in immunosuppressed patients remains unclear.

Methods: A systematic review and meta-analysis were performed for diagnostic test accuracy of IGRA in tuberculosis (TB) infection among people living with HIV (PLWHIV). Summary estimates of sensitivity and specificity were calculated using both univariate and bivariate models.

Results: The meta-analysis included 45 of the 1,242 first-screened articles. The total number of PLWHIV was 6,525; 3,467 had TB disease, including 806 cases of LTBI and 2,661 cases of active TB. The overall diagnostic odds ratio (DOR) of IGRA in the diagnosis of TB disease was 10.0 (95% confidence interval (CI) 5.59, 25.07), with an area under the curve (AUC) of 0.729. The DOR was better for QFT (14.2 (95%CI 4.359, 46.463)) than T-SPOT (10.0 (95%CI 3.866 26.033)). The sensitivity and specificity of QFT and T-SPOT were 0.663 (95%CI 0.471, 0.813), 0.867 (95%CI 0.683 0.942), and 0.604 (95%CI 0.481, 0.715), 0.862 (95%CI 0.654, 0.954), respectively, in the bivariate model. The sensitivity of IGRA in the diagnosis of LTBI was 0.64 (95%CI 0.61, 0.66).

Conclusion: IGRA was useful in the diagnostic of TB disease in PLWHIV, and QFT showed a better tendency of DOR than T-SPOT. IGRA showed a limited effect to rule out LTBI in PLWHIV.

Citing Articles

Advances in technology for the laboratory diagnosis of individuals with HIV/AIDS coinfected with .

Sun J, Han X, Yan H, Zhang X, Jiang T, Zhang T Biosaf Health. 2025; 6(3):133-142.

PMID: 40078723 PMC: 11895006. DOI: 10.1016/j.bsheal.2024.04.003.

Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report.

Pandey T, Inamdar S, Jeffus S, Pandey S, Varma A Cureus. 2025; 17(1):e78263.

PMID: 40026931 PMC: 11872240. DOI: 10.7759/cureus.78263.

Interferon-Gamma Release Assay Testing for Latent Tuberculosis Infection: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2025; 24(11):1-183.

PMID: 39911267 PMC: 11792883.

Quantum Dot-Based Nanosensors for In Vitro Detection of .

Nikolaev V, Lepekhina T, Alliluev A, Bidram E, Sokolov P, Nabiev I Nanomaterials (Basel). 2024; 14(19).

PMID: 39404280 PMC: 11478040. DOI: 10.3390/nano14191553.

Prevalence of latent tuberculosis infection (LTBI) in healthcare workers in Latin America and the Caribbean: systematic review and meta-analysis.

Meregildo-Rodriguez E, Ortiz-Pizarro M, Asmat-Rubio M, Rojas-Benites M, Vasquez-Tirado G Infez Med. 2024; 32(3):292-311.

PMID: 39282545 PMC: 11392545. DOI: 10.53854/liim-3203-4.

References

Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, Skroza N . Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis. 2010; 14(7):834-40. View

Stavri H, Ene L, Popa G, Duiculescu D, Murgoci G, Marica C . Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB. Roum Arch Microbiol Immunol. 2009; 68(1):14-9. View

Zhou G, Luo Q, Luo S, Teng Z, Ji Z, Yang J . Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2020; 20(12):1457-1469. DOI: 10.1016/S1473-3099(20)30276-0. View

Mwaba P, Chakaya J, Petersen E, Wejse C, Zumla A, Kapata N . Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?. Int J Infect Dis. 2020; 92S:S69-S71. DOI: 10.1016/j.ijid.2020.02.011. View

Kussen G, Dalla-Costa L, Rossoni A, Raboni S . Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil. Braz J Infect Dis. 2015; 20(1):69-75. PMC: 9425390. DOI: 10.1016/j.bjid.2015.10.007. View

Jiang W, Shao L, Zhang Y, Zhang S, Meng C, Xu Y . High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol. 2009; 10:31. PMC: 2700818. DOI: 10.1186/1471-2172-10-31. View

Petruccioli E, Chiacchio T, Navarra A, Vanini V, Cuzzi G, Cimaglia C . Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection. J Infect. 2020; 80(5):536-546. PMC: 8862140. DOI: 10.1016/j.jinf.2020.02.009. View

Tsiouris S, Coetzee D, Toro P, Austin J, Stein Z, El-Sadr W . Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006; 44(8):2844-50. PMC: 1594653. DOI: 10.1128/JCM.02411-05. View

Garcia-Elorriaga G, Martinez-Velazquez M, Gaona-Flores V, Del Rey-Pineda G, Gonzalez-Bonilla C . Interferon γ in patients with HIV/AIDS and suspicion or latent tuberculosis infection. Asian Pac J Trop Med. 2013; 6(2):135-8. DOI: 10.1016/S1995-7645(13)60009-7. View

10.

Kabeer B, Sikhamani R, Raja A . Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn Microbiol Infect Dis. 2011; 71(3):236-43. PMC: 3193601. DOI: 10.1016/j.diagmicrobio.2011.07.012. View

11.

Sattah M, Aye S, Azen C, Kort J, Escalante P, Jones B . Interferon-gamma release assay T-SPOT®.TB and HIV-related tuberculosis. Int J Tuberc Lung Dis. 2012; 16(2):281-2. DOI: 10.5588/ijtld.11.0441. View

12.

Klautau G, da Mota N, Salles M, Burattini M, Rodrigues D . Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study. BMC Infect Dis. 2018; 18(1):585. PMC: 6245697. DOI: 10.1186/s12879-018-3508-8. View

13.

Rangaka M, Gideon H, Wilkinson K, Pai M, Mwansa-Kambafwile J, Maartens G . Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. Eur Respir J. 2011; 39(1):163-71. PMC: 3568692. DOI: 10.1183/09031936.00058911. View

14.

Cattamanchi A, Ssewenyana I, Davis J, Huang L, Worodria W, den Boon S . Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis. 2010; 10:75. PMC: 2846947. DOI: 10.1186/1471-2334-10-75. View

15.

Oni T, Patel J, Gideon H, Seldon R, Wood K, Hlombe Y . Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J. 2010; 36(3):594-600. PMC: 3025278. DOI: 10.1183/09031936.00171509. View

16.

Clark S, Martin S, Pozniak A, Steel A, Ward B, Dunning J . Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol. 2007; 150(2):238-44. PMC: 2219352. DOI: 10.1111/j.1365-2249.2007.03477.x. View

17.

Fujita A, Ajisawa A, Harada N, Higuchi K, Mori T . Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons. Clin Dev Immunol. 2010; 2011. PMC: 2931370. DOI: 10.1155/2011/325295. View

18.

Auguste P, Tsertsvadze A, Pink J, Court R, McCarthy N, Sutcliffe P . Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2017; 17(1):200. PMC: 5343308. DOI: 10.1186/s12879-017-2301-4. View

19.

Caulfield A, Wengenack N . Diagnosis of active tuberculosis disease: From microscopy to molecular techniques. J Clin Tuberc Other Mycobact Dis. 2019; 4:33-43. PMC: 6850262. DOI: 10.1016/j.jctube.2016.05.005. View

20.

Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, Rianda A . IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect. 2012; 65(1):49-59. DOI: 10.1016/j.jinf.2012.03.017. View